Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today announced a strategic collaboration with Microsize and Micromacinazione, pioneers in pharmaceutical ...
In the global pharmaceutical manufacturing landscape, HK Neopharm Limited has been increasingly recognized by industry observers as a noteworthy participant in the active pharmaceutical ingredient ...
VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the initiation of pro ...
Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to ...
To combat severe domestic shortages driven by surging platinum and API costs, the NPPA has approved a one-time 50% price ...
VANCOUVER, BC / ACCESS Newswire / June 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered ...
The adviser expressed confidence that with policy consistency and sustained support, Bangladesh could emerge as a global player by 2030 ...
At this point in product development, acceleration is a natural urge. But while it’s tempting to prioritize speed, it’s ...
VANCOUVER, BC / ACCESS Newswire / June 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered i ...
GVRP and StepsBio unveils GSRC, the new CoE for formulations R&D: Our Bureau, Bengaluru Thursday, June 4, 2026, 14:40 Hrs [IST] GVRP (GV Research Platform), a Hyderabad-based rese ...
Ahmedabad-based Concord Biotech, an R&D-driven biopharma company, made a strong debut in the secondary market on August 18, ...
Using special tags embedded in the output, the model directly links every factual claim it makes to the specific source document or database row it pulled the information from.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results